A Randomized, Blinded Study to Compare Exparel and Ropivacaine for Pain Relief Following Total Knee Arthroplasty
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 02 May 2017
At a glance
- Drugs Bupivacaine (Primary) ; Ropivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 26 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.
- 26 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Nov 2015 New trial record